Ðǿմ«Ã½

    Advertisement
    In the last 6 hours
    RTT News12:22
    Earlier today
    PR Newswire (Press Release)08:35
    Yesterday
    Nature.com19:30 30-Sep-26
    Newswise (Press Release)17:04 30-Sep-26
    Medical Daily12:14 30-Sep-26
    Medpage Today10:51 30-Sep-26
    Hematology Advisor10:23 30-Sep-26
    News-Medical.Net07:56 30-Sep-26
    Biotech, B3C newswire03:02 30-Sep-26
    In the last 7 days
    Rare Disease Advisor16:27 29-Sep-26
    Newswise (Press Release)13:19 29-Sep-26
    China Money Network17:31 28-Sep-26
    PR Newswire (Press Release)07:06 28-Sep-26
    Business Wire (Press Release)06:46 28-Sep-26
    Nature.com03:06 28-Sep-26
    PR Newswire (Press Release)23:07 26-Sep-26
    Business Wire (Press Release)16:02 25-Sep-26
    PR Newswire (Press Release)11:33 25-Sep-26
    PR Newswire (Press Release)10:55 25-Sep-26
    News-Medical.Net10:16 25-Sep-26
    Clinical Trials Arena10:02 25-Sep-26
    ecancer09:41 25-Sep-26
    Newswise (Press Release)14:00 24-Sep-26
    pharmaphorum08:08 24-Sep-26
    RTT News08:00 24-Sep-26
    In the last month
    Business Wire (Press Release)09:06 23-Sep-26
    ecancer05:58 22-Sep-26
    Newswise (Press Release)16:25 21-Sep-26
    PR Newswire (Press Release)07:50 21-Sep-26
    STV07:45 19-Sep-26
    Newswise (Press Release)17:45 17-Sep-26
    Glasgow Evening Times07:04 17-Sep-26
    RTT News15:06 16-Sep-26
    PR Newswire (Press Release)14:24 16-Sep-26
    Benzinga11:37 16-Sep-26
    UCLH NHS Foundation Trust (Press Release)07:07 16-Sep-26
    Business Wire (Press Release)07:05 16-Sep-26
    PR Newswire (Press Release)05:52 16-Sep-26
    Scrip Pharma Intelligence04:00 16-Sep-26
    Hematology Advisor09:32 15-Sep-26
    Hematology Advisor09:32 15-Sep-26
    PR Newswire (Press Release)07:31 14-Sep-26
    Futurism10:08 13-Sep-26
    PR Newswire (Press Release)10:10 10-Sep-26
    pharmaphorum08:25 9-Sep-26
    Manufacturing Chemist08:07 9-Sep-26
    RTT News10:35 8-Sep-26
    NewsMax10:08 8-Sep-26
    Scrip Pharma Intelligence07:29 8-Sep-26
    The Times of India15:25 7-Sep-26
    European Pharmaceutical Manufacturer08:15 7-Sep-26
    STAT09:49 4-Sep-26
    Korea Biomedical Review00:52 4-Sep-26
    Drugs Discovery Online00:06 4-Sep-26
    Nature.com09:08 3-Sep-26
    Business Wire (Press Release)16:09 2-Sep-26
    News-Medical.Net13:30 2-Sep-26
    BioPharma Dive13:27 2-Sep-26
    Chemistry World Magazine12:58 2-Sep-26
    IAM06:28 2-Sep-26
    Medpage Today12:52 1-Sep-26
    Pharmaceutical Field07:24 1-Sep-26
    Manufacturing Chemist07:19 1-Sep-26
    pharmaphorum06:29 1-Sep-26
    Times LIVE02:15 1-Sep-26
    BioPharma Dive22:06 31-Aug-26
    view more headlines
    1 Oct 12:22

    About our CAR-T news

    Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.